Preferential photoinactivation of leukemia cells by aluminum phthalocyanine

Journal of Photochemistry and Photobiology B: Biology

Volumn 43, Issue 2, 1998, Pages 128-135

  Daziano, Jean Pierre ^a   Humeau, Laurent ^b   Henry, Monique ^a   Mannoni, Patrice ^b   Chanon, Michel ^a   Chabannon, Christian ^b   Julliard, Michel ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

^b INSTITUT PAOLI CALMETTES   (France)

Author keywords

Bone marrow purging; Leukemia; Photodynamic therapy (PDT); Phthalocyanines; Progenitors; Selectivity

Indexed keywords

PHTHALOCYANINE ALUMINUM;

ARTICLE; CELL KILLING; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LEUKEMIA CELL; LEUKOCYTE; PERIPHERAL BLOOD STEM CELL; PHOTODYNAMIC THERAPY; PHOTOTOXICITY; PRIORITY JOURNAL;

ALUMINUM; ANTIGENS, CD34; CELLS, CULTURED; HEMATOPOIETIC STEM CELLS; HUMANS; INDOLES; LEUKEMIA, ERYTHROBLASTIC, ACUTE; LEUKEMIA, MYELOCYTIC, ACUTE; LEUKOCYTES; LIGHT; ORGANOMETALLIC COMPOUNDS; PHOTOCHEMOTHERAPY; REFERENCE VALUES; TUMOR CELLS, CULTURED;

EID: 0032524369     PISSN: 10111344     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1011-1344(98)00095-5     Document Type: Article

References (38)

1. [1] J. Reiffers, A.M. Stoppa, Allogeneic versus autologous BMT versus chemotherapy for treatment of acute myeloid leukemia in first remission, Bone Marrow Trans. 7 (suppl. 2) (1991) 36-37.
2. [2] A.B. Deisseroth, Z. Zu, D. Claxton, E.G. Hanania, S. Fu, D. Ellerson, L. Goldberg, M. Thomas, K. Janicek, W.F. Anderson, J. Hester, M. Korbling, A. Durett, R. Moen, R. Berenson, S. Heimfeld, H. Hamer, L. Calvert, P. Tibbits, M. Talpaz, H. Kantarjia, R. Champlin, R. Reading, Genetic marking shows that Ph+ cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow transplantation in CML, Blood 83 (1994) 3068-3076.
3. [3] M.K. Brenner, D.R. Rill, R.C. Moen, R.A. Krance, J. Mirro, W.F. Anderseon, J.N. IhIe, Gene-marking to trace origin of relapse after autologous bone marrow transplantation, Lancet 341 (1993) 85-86.
4. [4] L. Douay, N.C. Gorin, J.P. Laporte, M. Lopez, A. Najman, G. Duhamal, ASTA Z 7557 (INN mafosfamide) for the in vitro treatment of human leukemic bone marrows. Invest. New Drugs 2 (1984) 187-190.
5. [5] N.C. Gorin, L. Douay, J.P. Laporte, M. Lopez, J.Y. Mary, A. Najman, C. Salmon, P. Aegerter, J. Stachowiak, R. David. F. Pene, G. Kantor, J. Deloux, E. Duhamel, J. Van den Akker, J. Gerota, Y. Parlier, G. Duhamel, Autologous bone marrow transplantation using marrow incubated with Asta Z 7557 in adult acute leukemia, Blood 67 (1986) 1367-1376.
6. [6] H.C, Kluin-Nelemans, A.C.M. Martens, B. Löwenberg, A. Hagenbeek, No preferential sensitivity of clonogenic cells to ASTA-7-7557, Leukaemia Res. 8 (1984) 723-728.
7. [7] S.D. Rowley, M. Zuehlsdorf, H.G. Braine, M. Colvin, J. Davis, R.J. Jones, R. Saral, L.L. Sensenbrenner, A. Yeager, G.W. Santos, CFU-GM content of bone marrow grafts correlates with time to hematologic reconstitution following autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide-purged bone marrow, Blood 70 (1987) 271-275.
8. [8] C.R.J. Singer, D.C. Linch, Comparison of the sensitivity of normal and leukaemic myeloid progenitors to in vitro incubation with cytotoxic drugs: a study of pharmacological purging, Leukaemia Res. 11 (1987) 953-959.
9. [9] F. Beaujean, O. Hartmann, J.L. Pico, C. Parmentier, M. Hayat, N. DuÈdari, J. Lemerle, Incubation of autologous bone marrow graft with ASTA Z-7557: comparative studies of hematological reconstitution after purged or non purged bone marrow transplantation, Pediatr. Hematol. Oncol. 4 (1987) 105-115.
10. [10] G.J. Levy, C. Dowding, D. Mitchell, R. Sorrenti, S. Yip, C. Jamieson, Selective elimination of malignant stem cells using photosensitizers followed by light treatment, Stem Cells 13 (1995) 336-343.
11. [11] T.J. Dougherty, Photosensitizers: therapy and detection of malignant tumors, Photochem. Photobiol. 45 (1987) 879-889.
12. [12] M. Kremer-Birnbaum, Modified porphyrins, chlorins, phthalocyanines, and purpurins: second-generation photosensitizers for photodynamic therapy, Seminars in Hematology 26 (1989) 157-173.
13. [13] T.J. Dougherty, Photodynamic therapy, in: D. Kessel (Ed.), Methods in Porphyrin Photosensitization, New York Press, pp. 313-328.
14. [14] C.J. Corner, What makes a good photosensitizer for photodynamic therapy?, J. Photochem, Photobiol, B: Biol. 1 (1989) 376-378.
15. [15] E. Ben-Hur, I. Rosenthal, The phthalocyantnes: a new class of mammalian cells photosensitizers with a potential for cancer phototherapy, Int. J. Radiat. Biol. 47 (1985) 145-147.
16. [16] E. Ben-Hur, I. Rosenthal, Photosensitized inactivation of Chinese hamster cells by phthalocyanines, Photochem. Photobiol. 42 (1985) 129-133.
17. [17] W.S. Chan, J.F. Marshall, R. Swensen, D. Phillips, I.R. Hart, Photosensitizing activity of phthalocyanine dyes screened against tissue culture cells, Photochem. Photobiol. 45 (1987) 757-761.
18. [18] E. Ben-Hur, I. Rosenthal, Factors affecting the photokilling of cultured Chinese hamster cells by phthalocyanines, Radiat. Res. 103 (1985) 403-409.
19. [19] J.R. Darwent, P. Douglass, A. Harriman, G. Porter, M.C. Richoux, Metal phthalocyanines and porphyrins as sensitizers for reduction of water to hydrogen, Coord. Chem. Rev. 44 (1982) 83-126.
20. [20] J.R. Wagner, H. Ali, R. Langlois, N. Brasseur, J.E. Van Lier, Biological activities of phthalocyanines - VI. Photooxidation of L-tryptophan by selectively sulfonated gallium phthalocyanines: singlet oxygen yields and effect of aggregation, Photochem. Photobiol. 45 (1987) 587-594.
21. [21] M. Paardehooker, A.E. Van Compel, H.J.G.M. De Bont, J.F. Nagelkerke, J. Van Stevenick, P.J.A. Van Den Broek, Photodynamic treatment of yeast with chloroaluminum phthalocyanines: role of the monomeric form of the dye, Photochem. Photobiol. 59 (1994) 161-166.
22. [22] F. Sieber, S. Rao, S.L. Shober, M. Sieber Blum, Dye-mediated photolysis of human neuroblastama cells: implication for autologous bone marrow transplantation, Blood 73 (1987) 1059-1065.
23. [23] K.S. Gulliya, S. Pervaiz, Elimination of clonogenic tumor cells from HL-60, Daudi and U-937 cell lines: implication for autologous marrow transplantation, Blood 73 (1989) 1059-1066.
24. [24] E. Fibach, A. Rabia, S. Gatt, Pyrene butanol an efficient, selective and non-metabolized photosensitizing agent for human myeloid leukemia cells, Leukaemia Res. 16 (1992) 453-462.
25. [25] C.H.M. Jamieson, W.N. McDonald, J.G. Levy, Preferential uptake of benzoporphyrin derivative by leukemic versus normal cells. Leukaemia Res. 14 (1990) 209-219.
26. [26] C.R.J. Singer, D.C. Linch, S.G. Bown, E.R. Huens, A.H. Goldstone, Differential phthalocyanine photosensitisation of acute myeloblastic leukaemia progenitor cells: a potential purging technique for autologous bone marrow transplantation, Br. J. Hematol. 68 (1988) 417-422.
27. [27] C.R.J. Singer, S.G. Brown, D.C. Linch, E.R. Huehns, A.H. Goldstone, Phthalocyanine photosensitization for in vitro elimination of residual acute nonlymphoblastic leukemia: preliminary evaluation, Photochem. Photobiol. 46 (1987) 745-749.
28. [28] L.B. To, D.N. Haylock, P.J. Simmons, C.A. Juttner, The biology and clinical use of blood stem cells, Blood 89 (1997) 2233-2258.
29. [29] T. Kitamura, T. Tange, T. Terasawa, S. Chiba, T. Kuwaki, K. Miyagawa, Y. Piao, K, Miazono, A. Urabe, F, Takaru, Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3 or erythropoietin, J. Cell. Physiol. 140 (1989) 323-334.
30. [30] M. Fiedorowicz, J.R. Galindo, M. Julliard, P. Mannoni, M. Chanon, Efficient photodynamic action of Victoria blue Bo against the human leukemic cell lines TF-1 and K-562, Photochem. Photobiol. 58 (1993) 356-361.
31. [31] D. Metcalf, Techniques for the Clonal Culture of Hemopoietic Cells, Techniques and Applications, Elsevier, New York, 1984.
32. [32] J.P. Daziano, S. Steenken, C. Chabannon, P. Mannoni, M. Chanon, M. Julliard, Photophysical and redox properties of a series of phthalocyanines. Relation with their photodynamic activity on TF-1 and DAUDI leukemic cells, Photochem. Photobiol. 64 (1996) 712-719.
33. [33] T. Yamazaki, Y. Sato, F. Sieber, Role of cytoprotective mechanisms in the photochemical purging of autologous marrow grafts, Exp. Hematol. 25 (1997) 629-637.
34. [34] G. Jori, In vivo transport and pharmacokinetic behavior of tumor photosensitizers, in: Photosensitizing Compounds: Their Chemistry, Biology and Clinical Use (Ciba Foundation Symposium 146), John Wiley, Chichester, 1989, pp. 78-94.
35. [35] W.F. Keir, E.J. Land, A.M. McLennan, D.J. McGarvey, T.G. Truscott, Pulsed radiation studies of photodynamic sensitizers: the nature of DHE, Photochem. Photobiol. 46 (1987) 587-589.
36. [36] E. Ben-Hur, A. Carmichael, P. Riesz, I. Rosenthal, Photochemical generation of superoxide radical and the cytotoxicity of phthalocyanines, Int. J. Radiat. Biol. 47 (1985) 837-846.
37. [37] T. Takemura, N. Ohta, S. Nakajima, I. Sakata, Critical importance of the triplet lifetime of photosensitizer in photodynamic therapy of tumours, Photochem. Photobiol. 50 (1989) 339-344.
38. [38] F. Sieber, Phototherapy, photochemotherapy, and bone marrow transplantation, J. Hematotherapy 2 (1993) 43-62.